Nanobiotix Files 6-K on Insider Transactions
Ticker: NBTX · Form: 6-K · Filed: Apr 14, 2025 · CIK: 1760854
| Field | Detail |
|---|---|
| Company | Nanobiotix S.A. (NBTX) |
| Form Type | 6-K |
| Filed Date | Apr 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: insider-transaction, disclosure, 6-K
TL;DR
Nanobiotix filed a 6-K detailing insider transactions from December 2024.
AI Summary
On April 14, 2025, Nanobiotix S.A. filed a Form 6-K to disclose transactions by persons discharging managerial responsibilities. The filing pertains to the month of December 2024 and was submitted as a report of a foreign private issuer.
Why It Matters
This filing provides transparency into the trading activities of Nanobiotix's key personnel, which can offer insights into their confidence in the company's future prospects.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of managerial transactions and does not contain significant new financial or operational information.
Key Players & Entities
- Nanobiotix S.A. (company) — Registrant
- 001-39777 (company) — Commission File Number
- April 14, 2025 (date) — Filing Date
- December 2024 (date) — Reporting Period for Transactions
FAQ
What type of transactions are disclosed in this Form 6-K?
This Form 6-K discloses transactions by persons discharging managerial responsibilities.
What is the Commission File Number for Nanobiotix S.A.?
The Commission File Number for Nanobiotix S.A. is 001-39777.
When was this Form 6-K filed?
This Form 6-K was filed on April 14, 2025.
For which month do the disclosed transactions pertain?
The transactions disclosed in this report pertain to the month of December 2024.
What is the principal executive office address of Nanobiotix S.A.?
The principal executive office address of Nanobiotix S.A. is 60 rue de Wattignies, 75012 Paris, France.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 14, 2025 regarding Nanobiotix S.A. (NBTX).